Rory B. Riggs, Director at Royalty Pharma plc (RPRX), sold 90,000 shares at $43.73 ($3.9M) on 2022-08-09, disclosed to the SEC on 2022-08-11.
Open-market sale of $3.9M RPRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.73 | 45,000 | $2.0M | 50.0% |
| 2 | $43.73 | 45,000 | $2.0M | 50.0% |
| Total | $43.73 avg | 90,000 | $3.9M | 100% |
| Filing → |
| CBUS | BUY | 2023-12-14 | $10.9M | — | Filing → |
| CBUS | BUY | 2023-06-02 | $32K | — | Filing → |
| RPRX | SELL | 2023-05-22 | $57.4M | — | Filing → |